Optimizing health outcomes in active epilepsy

Neurology

Volumn 58, Issue 8 SUPPL. 4, 2002, Pages

  Gilliam, Frank ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

AGGRESSION; AMNESIA; BRAIN SURGERY; DEPRESSION; DRUG RESPONSE; EPILEPSY; FATIGUE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEADACHE; HEALTH STATUS; HUMAN; NERVOUSNESS; PATIENT EDUCATION; PERCEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESSNESS; REVIEW; SKIN DISEASE; SLEEP DISORDER; SOMNOLENCE; TREATMENT OUTCOME; TREATMENT PLANNING; VERTIGO; VISUAL DISORDER;

EID: 0037161376     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.58.8_suppl_5.s9     Document Type: Review

References (54)

1. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984
2. Office visits to neurologists
3. Early identification of refractory epilepsy
4. Long-term prognosis of seizures with onset in childhood
5. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures
6. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults
7. Prognosis for total control of complex partial and secondarily generalized tonic-clonic seizures
8. Health outcomes in persons with epilepsy
9. A randomized, controlled trial of surgery for temporal-lobe epilepsy
10. Temporal lobectomy for refractory epilepsy
11. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy
12. Anterior temporal lobectomy for complex partial seizures: Evaluation, results, and long-term follow-up in 100 cases
13. Outcomes research: Measuring the end results of health care
14. A clinimetric approach to assessing quality of life in epilepsy
15. Outcome assessment for epilepsy surgery: The impact of measuring health-related quality of life
16. Patient-validated content of epilepsy-specific quality-of-life measurement
17. Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms
18. Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study
19. Seizure control and mortality in epilepsy
20. Failure of standard magnetic resonance imaging in patients with refractory temporal lobe epilepsy
21. Preoperative MRI predicts outcome of temporal lobectomy: An actuarial analysis
22. Longitudinal follow-up in 145 patients with medically refractory temporal lobe epilepsy treated surgically between 1984 and 1995
23. Seizure outcome after temporal lobectomy for temporal lobe epilepsy: A Kaplan-Meier survival analysis
24. Association of combined MRI, interictal EEG, and ictal EEG results with outcome and pathology after temporal lobectomy
25. Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: A multivariate study
26. Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery
27. Health-related quality of life and seizure control in temporal lobe epilepsy
28. The subjective handicap of epilepsy. A new approach to measuring treatment outcome
29. Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy
30. Epilepsy surgery outcome: Comprehensive assessment in children
31. Finally, a randomized, controlled trial of epilepsy surgery
32. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre
33. Epilepsy, vagal nerve stimulation by the NCP system, mortality, and sudden, unexpected, unexplained death
34. Surgical and neurological complications in a series of 708 epilepsy surgery procedures
35. Patients' experiences of injury as a result of epilepsy
36. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults
37. Differential cognitive effects of carbamazepine and gabapentin
38. Differential cognitive and behavioral effects of carbamazepine and lamotrigine
39. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure
40. Quality of life of people with epilepsy: A European study
41. Initial development, reliability, and validity of a patient-based adverse events scale
42. Development of the quality of life in epilepsy inventory
43. Screening for depression in diabetes using the Beck Depression Inventory
44. Depression in epilepsy: Etiology, phenomenology, and treatment
45. Interictal depression in epilepsy
46. The clinical course of epilepsy and its psychosocial correlates: Findings from a U.K. Community study
47. The associations of psychopathology in epilepsy: A community study
48. Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice
49. Depression in epilepsy. Significance and phenomenology
50. Depressive illness in patients with epilepsy: A review
51. Assessing the psychosocial consequences of epilepsy: A community-based study
52. The relationship of neuropsychological functioning to quality of life in epilepsy
53. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients